Health authorities in the Democratic Republic of Congo have introduced a new Ebola vaccine produced by Johnson & Johnson, aid group Doctors Without Borders (MSF) said on Thursday, to help combat the world's second-worst outbreak of the virus on record, Reuters told.
The new vaccine, produced by a Belgian subsidiary of Johnson & Johnson, will be administered to about 50,000 people over four months, the charity said. The campaign will take place in Goma, a city of two million on the Rwandan border, MSF said.
Over 250,000 people, many of them frontline health workers, have been immunised with another anti-Ebola vaccine in a programme begun last year.The notorious haemorrhagic virus has so far killed 2,193 people, according to the latest official figures.The outbreak is second only to the 2013-16 West African outbreak that killed more than 11,300.The new vaccine has passed clinical trials but has never been tested in a real-world setting.The vaccine, which requires two injections eight weeks apart, will be rolled out alongside another manufactured by Merck, which only requires a single shot.
Bütün xəbərlər Facebook səhifəmizdə
.jpg)
.jpg)
.jpg)
.jpg)
USD
EUR
GBP
RUB